179 related articles for article (PubMed ID: 8144952)
1. Superantigen-like properties of an antibody bispecific for MHC class II molecules and the V beta domain of the T cell antigen receptor.
Yagi J; Nakata M; Uchiyama T; Nishikawa M; Mizushima Y; Nishioka K; Ito K; Yagita H; Okumura K; Janeway CA
J Immunol; 1994 Apr; 152(8):3833-41. PubMed ID: 8144952
[TBL] [Abstract][Full Text] [Related]
2. The J alpha segment contributes to the affinity of V beta 6+ cells for vSAG-7 (Mls-1a) presented by I-A molecules.
Churaqui E; Oukka M; Tilloy F; Mayadoux E; Bruley-Rosset M; Kosmatopoulos K
Immunology; 1995 Apr; 84(4):609-18. PubMed ID: 7790035
[TBL] [Abstract][Full Text] [Related]
3. Presentation of the Mls-1 superantigen by human HLA class II molecules to murine T cells.
Subramanyam M; McLellan B; Labrecque N; Sekaly RP; Huber BT
J Immunol; 1993 Sep; 151(5):2538-45. PubMed ID: 8395548
[TBL] [Abstract][Full Text] [Related]
4. A novel HLA class II-independent TCR-mediated T cell activation mechanism is distinguished by the V beta specificity of the proliferating oligoclones and their capacity to generate interleukin-2.
Dennig D; Yan Y; Ferguson K; O'Reilly RJ
Cell Immunol; 1996 Aug; 171(2):200-10. PubMed ID: 8806788
[TBL] [Abstract][Full Text] [Related]
5. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P
J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
[TBL] [Abstract][Full Text] [Related]
6. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
[TBL] [Abstract][Full Text] [Related]
7. Regulation of superantigen-induced T cell activation in the absence and the presence of MHC class II.
Lando PA; Olsson C; Kalland T; Newton D; Kotb M; Dohlsten M
J Immunol; 1996 Oct; 157(7):2857-63. PubMed ID: 8816390
[TBL] [Abstract][Full Text] [Related]
8. Variable influence of MHC polymorphism on the recognition of bacterial superantigens by T cells.
Wen R; Blackman MA; Woodland DL
J Immunol; 1995 Aug; 155(4):1884-92. PubMed ID: 7636239
[TBL] [Abstract][Full Text] [Related]
9. Activation of murine T cells by streptococcal pyrogenic exotoxin type A. Requirement for MHC class II molecules on accessory cells and identification of V beta elements in T cell receptor of toxin-reactive T cells.
Imanishi K; Igarashi H; Uchiyama T
J Immunol; 1990 Nov; 145(10):3170-6. PubMed ID: 2230113
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the Mlsf system. I. A novel "polymorphism" of endogenous superantigens.
Abe R; Foo-Phillips M; Granger LG; Kanagawa O
J Immunol; 1992 Dec; 149(11):3429-39. PubMed ID: 1331235
[TBL] [Abstract][Full Text] [Related]
11. Control of the rat T cell response to retroviral and bacterial superantigens by class II MHC products and Tcrb-V8.2 alleles.
Herrmann T; Hochgrebe T; Torres-Nagel NE; Huber BT; Hünig T
J Immunol; 1994 May; 152(9):4300-9. PubMed ID: 8157953
[TBL] [Abstract][Full Text] [Related]
12. Preservation of the specificity of superantigen to T cell receptor V beta elements in the absence of MHC class II molecules.
Kotb M; Watanabe-Ohnishi R; Aelion J; Tanaka T; Geller AM; Ohnishi H
Cell Immunol; 1993 Dec; 152(2):348-57. PubMed ID: 8258143
[TBL] [Abstract][Full Text] [Related]
13. A V beta 4-specific superantigen encoded by a new exogenous mouse mammary tumor virus.
Maillard I; Erny K; Acha-Orbea H; Diggelmann H
Eur J Immunol; 1996 May; 26(5):1000-6. PubMed ID: 8647159
[TBL] [Abstract][Full Text] [Related]
14. MHC-specific recognition of a bacterial superantigen by weakly reactive T cells.
Surman S; Deckhut AM; Blackman MA; Woodland DL
J Immunol; 1994 May; 152(10):4893-902. PubMed ID: 8176210
[TBL] [Abstract][Full Text] [Related]
15. Interaction between superantigen and T-cell receptor Vbeta element determines levels of superantigen-dependent cell-mediated cytotoxicity of CD8(+) T cells in induction and effector phases.
Li ZJ; Omoe K; Shinagawa K; Yagi J; Imanishi K
Microbiol Immunol; 2009 Aug; 53(8):451-9. PubMed ID: 19659929
[TBL] [Abstract][Full Text] [Related]
16. MHC class II A alpha and E alpha molecules determine the clonal deletion of V beta 6+ T cells. Studies with recombinant and transgenic mice.
Anderson GD; Banerjee S; David CS
J Immunol; 1989 Dec; 143(11):3757-61. PubMed ID: 2531186
[TBL] [Abstract][Full Text] [Related]
17. Intercellular adhesion molecule-1 and leukocyte function-associated antigen-3 provide costimulation for superantigen-induced T lymphocyte proliferation in the absence of a specific presenting molecule.
Lamphear JG; Stevens KR; Rich RR
J Immunol; 1998 Jan; 160(2):615-23. PubMed ID: 9551895
[TBL] [Abstract][Full Text] [Related]
18. Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury.
Brogan PA; Shah V; Klein N; Dillon MJ
Arthritis Rheum; 2004 Feb; 50(2):589-97. PubMed ID: 14872503
[TBL] [Abstract][Full Text] [Related]
19. The expression of CD4 and CD8 molecules conditions the behavior of V beta + murine thymocytes upon superantigenic challenge.
Fattorossi A; Baschieri S; Ferlini C; Doria G
Thymus; 1997; 24(3):133-45. PubMed ID: 9151379
[TBL] [Abstract][Full Text] [Related]
20. Xenogeneic cells and superantigen induce human T-cell activation in the absence of T-cell recognition of xenoantigen.
Diaz LA; Pai R; Endres J; Anthony P; Duzyj C; Bishu S; Morita Y; Fox DA
J Lab Clin Med; 2003 Sep; 142(3):149-57. PubMed ID: 14532902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
